Audrey Lee focuses her practice on corporate matters, including high profile transactions, mergers, acquisitions, and private equity transactions. Audrey’s experience spans industries such as biopharmaceuticals, entertainment and IT startups. She also has deep in-house experience, having served as general counsel of a venture-backed pharmaceutical company until its initial public offering. In this role, she oversaw legal matters related to cross-border life sciences licensing transactions, corporate litigation, intellectual property, initial public offerings, and labor and health care law. Building on such broad experience across different fields and industries, Audrey’s practice extends to international arbitration matters, where she liaises with international clients. In her role as chief operating and legal officer of an IT start-up, she handled the organization’s legal and operational matters. Prior to practicing law, Audrey was an investment banker at JP Morgan.
Experience
Mergers & Acquisitions
• Represented a Korean company in the media industry in the exit of its Australian parent.°
• Represented DKSH in its acquisition of Bosung Scientific.°
• Represented SK Telecom in its joint venture with Uber B.V. to launch T’Map Mobility, and further advised SK Telecom in its fundraising from private equity clients.°
• Represented a Chinese buyer in its acquisition of a semiconductor company in Korea.°
• Represented a Korean conglomerate in its acquisition of a paint manufacturer company in the Middle East.°
• Represented JKL Partners in its investment into T’Way Air.°
• Represented Korean shareholders in the sale of their stake in two Singapore technology companies to a purchaser based in American Samoa.°
• Advised Dongwon Enterprise in the acquisitions by the Dongwon Group’s subsidiaries of their respective targets in consumer retail industry and alternative battery technology industry.°
• Represented Bird Rides Europe B.V. in its investment into Bird Rides Korea.°
• Represented founding shareholders in the sale of KNet Co. Ltd to Hexatronic Group AB.°
• Represented STraffic Co., Ltd. in the spin-off of its electric vehicle charging business and investment into SSCharger Co., Ltd. with SK Networks and Anchor Equity Partners.°
• Represented Korean conglomerate in the establishment of and investment into a joint venture in United Arab Emirates.°
• Represented JKL Partners in its co-investment into Fulcrum BioEnergy.°
• Represented Mibelle in its acquisition of Gowoonsesang Cosmestics.°
Financing
• Represented Korea Resources Corporation in its restructuring of Ambatovy Project in Madagascar.°
• Represented a Korean film producing and distributing company in its foreign investments.°
Life Sciences Transactions
• Regularly advises Korean pharmaceutical companies in their on-going legal matters.°
• Represented OliPass in its licensing-out transaction of its PNA technology for certain rare disease targets to a U.S. company.°
• Represented a Korean pharmaceutical company in its licensing-in transaction for a certain protein inhibiting technology from a foreign partner.°
• Represented Voronoi in its licensing-out agreement with METiS Therapeutics for a pan-RAF inhibitor program.°
• Represented Qurient in its licensing-out agreement with TB Alliance for Telacebec (Q203) for treatment of tuberculosis.°
°The above representations were handled by Ms. Lee prior to her joining Greenberg Traurig, LLP.
In-House Experience
• General Counsel, Olipass Corporation, 2016-2020
• Chief Operating & Legal Officer, Mango Plate, Ltd, 2015-2016
Teaching Experience
• Adjunct Professor, Hankuk University of Foreign Studies, International Economics and Law, 2019-Present
Internships
• Summer Honors Law Program, Enforcement Division, U.S. Securities and Exchange Commission, 2008
